Tumor Necrosis Factor Alpha Inhibitor Therapy and Cancer Risk In Chronic Immune Mediated Diseases

BACKGROUND: We compared the incidence of cancer following tumor necrosis factor alpha antagonists (TNF-I) therapy to that with commonly used alternative therapies across multiple immune mediated diseases. METHODS: The Safety Assessment of Biologic thERapy (SABER) study used data from national Medica...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Haynes, Kevin, Beukelman, Timothy, Curtis, Jeffrey R, Newcomb, Craig, Herrinton, Lisa J, Graham, David J, Solomon, Daniel H, Griffin, Marie R, Chen, Lang, Liu, Liyan, Saag, Kenneth G, Lewis, James D
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3778442/
https://ncbi.nlm.nih.gov/pubmed/23055441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.37740
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados